Terrassa, Spain

Antoni Torrens-Jover

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Barcelona, ES (2000 - 2020)
  • Terrassa, ES (2016 - 2020)

Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Inventor Profile: Antoni Torrens-Jover

Introduction

Antoni Torrens-Jover is an accomplished inventor based in Terrassa, Spain, renowned for his significant contributions to the pharmaceutical field. With a remarkable portfolio of nine patents, he has been instrumental in developing innovative solutions for various therapeutic applications.

Latest Patents

Among his latest inventions, Torrens-Jover has developed the following noteworthy patents:

1. **1-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)ethanone salts** - This invention relates to specific salts of ethanone, notably hydrochloride and maleate forms, and includes pharmaceutical compositions that utilize these salts for the therapy and prevention of sigma receptor-associated diseases.

2. **Arylamide derivatives having multimodal activity against pain** - This patent focuses on arylamide derivatives that exhibit dual pharmacological action towards both the α2δ subunit of voltage-gated calcium channels and the μ-opioid receptor. It encompasses the synthesis of these compounds, their pharmaceutical compositions, and their applications in pain management therapies.

Career Highlights

Throughout his career, Torrens-Jover has worked with prominent companies in the pharmaceutical industry, including Laboratorios del Dr. Esteve S.A. and Esteve Pharmaceuticals, S.A. His efforts have greatly contributed to advancements in therapeutic substances and have established him as a leading figure in the realm of innovative medical solutions.

Collaborations

Collaboration is a vital aspect of Torrens-Jover's work. He has partnered with notable colleagues such as Carmen Almansa-Rosales and Jordi Frigola-Constansa, fostering innovative approaches in their collective research efforts and enhancing the development of pioneering medical treatments.

Conclusion

Antoni Torrens-Jover's dedication to innovation and his extensive patent portfolio highlight his crucial role in advancing pharmaceutical technology. As he continues to collaborate and innovate, his contributions are poised to make lasting impacts on healthcare and therapeutic practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…